Securian Asset Management Inc. Has $1.22 Million Stock Position in Axon Enterprise, Inc $AXON

Securian Asset Management Inc. reduced its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 44.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,140 shares of the biotechnology company’s stock after selling 1,686 shares during the quarter. Securian Asset Management Inc.’s holdings in Axon Enterprise were worth $1,215,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. New Millennium Group LLC bought a new stake in shares of Axon Enterprise during the third quarter worth approximately $29,000. Sound Income Strategies LLC boosted its stake in Axon Enterprise by 550.0% in the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after acquiring an additional 44 shares during the last quarter. Camelot Portfolios LLC bought a new stake in shares of Axon Enterprise during the 4th quarter valued at $30,000. Root Financial Partners LLC acquired a new position in shares of Axon Enterprise in the 3rd quarter valued at $34,000. Finally, Lodestone Wealth Management LLC acquired a new position in shares of Axon Enterprise in the 4th quarter valued at $35,000. Institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 157 shares of the stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $490.00, for a total transaction of $76,930.00. Following the completion of the transaction, the director owned 1,159 shares in the company, valued at approximately $567,910. This represents a 11.93% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Isaiah Fields sold 2,000 shares of the business’s stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $535.01, for a total value of $1,070,020.00. Following the completion of the sale, the insider owned 55,588 shares in the company, valued at approximately $29,740,135.88. This trade represents a 3.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 13,855 shares of company stock valued at $7,109,828 over the last quarter. 5.70% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. Morgan Stanley set a $600.00 price objective on Axon Enterprise in a research note on Thursday, May 7th. Robert W. Baird set a $800.00 price target on Axon Enterprise in a research note on Wednesday, February 25th. UBS Group cut their price target on shares of Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a research report on Thursday, May 7th. JPMorgan Chase & Co. lifted their price objective on shares of Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Finally, William Blair reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 3rd. Sixteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $712.75.

Axon Enterprise Trading Down 0.2%

NASDAQ:AXON opened at $393.66 on Wednesday. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $885.91. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93. The stock has a market capitalization of $31.73 billion, a PE ratio of 158.10, a price-to-earnings-growth ratio of 9.28 and a beta of 1.44. The business’s 50-day simple moving average is $443.50 and its 200-day simple moving average is $521.18.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The business had revenue of $807.35 million during the quarter, compared to analysts’ expectations of $778.91 million. During the same period in the prior year, the business earned $1.47 EPS. Axon Enterprise’s revenue for the quarter was up 33.7% compared to the same quarter last year. Sell-side analysts expect that Axon Enterprise, Inc will post 1.41 earnings per share for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.